# Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test

> **NCT04264468** · — · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer

## Interventions

- **COMBINATION_PRODUCT:** neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT04264468
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-14
- **Primary completion:** 2020-03-31
- **Final completion:** 2021-03-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264468, "Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04264468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*